Bogachek MV - Search Results

1

Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas.

Bogachek MV, Park JM, De Andrade JP, Lorenzen AW, Kulak MV, White JR, Gu VW, Wu VT, Weigel RJ. Bogachek MV, et al. Stem Cell Reports. 2016 Dec 13;7(6):1140-1151. doi: 10.1016/j.stemcr.2016.11.001. Epub 2016 Dec 1. Stem Cell Reports. 2016. PMID: 27916539 Free PMC article.

2

Sumoylation pathway is required to maintain the basal breast cancer subtype.

Bogachek MV, Chen Y, Kulak MV, Woodfield GW, Cyr AR, Park JM, Spanheimer PM, Li Y, Li T, Weigel RJ. Bogachek MV, et al. Cancer Cell. 2014 Jun 16;25(6):748-61. doi: 10.1016/j.ccr.2014.04.008. Epub 2014 May 15. Cancer Cell. 2014. PMID: 24835590 Free PMC article.

3

A novel animal model for locally advanced breast cancer.

Bogachek MV, Park JM, De Andrade JP, Kulak MV, White JR, Wu T, Spanheimer PM, Bair TB, Olivier AK, Weigel RJ. Bogachek MV, et al. Ann Surg Oncol. 2015 Mar;22(3):866-73. doi: 10.1245/s10434-014-4174-8. Epub 2014 Oct 18. Ann Surg Oncol. 2015. PMID: 25326397 Free PMC article.

4

Regulation of epithelial-mesenchymal transition through SUMOylation of transcription factors.

Bogachek MV, De Andrade JP, Weigel RJ. Bogachek MV, et al. Cancer Res. 2015 Jan 1;75(1):11-5. doi: 10.1158/0008-5472.CAN-14-2824. Epub 2014 Dec 18. Cancer Res. 2015. PMID: 25524900 Free PMC article. Review.

5

Targeting the sumoylation pathway in cancer stem cells.

Bogachek MV, De Andrade JP, Weigel RJ. Bogachek MV, et al. Mol Cell Oncol. 2014 Dec 23;1(3):e964624. doi: 10.4161/23723548.2014.964624. eCollection 2014 Jul-Sep. Mol Cell Oncol. 2014. PMID: 27308355 Free PMC article.

6

Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer.

De Andrade JP, Lorenzen AW, Wu VT, Bogachek MV, Park JM, Gu VW, Sevenich CM, Cassady VC, Beck AC, Kulak MV, Robinson RA, Lal G, Weigel RJ. De Andrade JP, et al. Among authors: bogachek mv. Oncotarget. 2017 Oct 23;8(70):114801-114815. doi: 10.18632/oncotarget.21954. eCollection 2017 Dec 29. Oncotarget. 2017. PMID: 29383121 Free PMC article.

7

TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis.

Cyr AR, Kulak MV, Park JM, Bogachek MV, Spanheimer PM, Woodfield GW, White-Baer LS, O'Malley YQ, Sugg SL, Olivier AK, Zhang W, Domann FE, Weigel RJ. Cyr AR, et al. Among authors: bogachek mv. Oncogene. 2015 Jan 22;34(4):436-44. doi: 10.1038/onc.2013.569. Epub 2014 Jan 27. Oncogene. 2015. PMID: 24469049 Free PMC article.

8

Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer.

Kulak MV, Cyr AR, Woodfield GW, Bogachek M, Spanheimer PM, Li T, Price DH, Domann FE, Weigel RJ. Kulak MV, et al. Among authors: bogachek m. Oncogene. 2013 Aug 22;32(34):4043-51. doi: 10.1038/onc.2012.400. Epub 2012 Sep 10. Oncogene. 2013. PMID: 22964634 Free PMC article.

9

Characterization of glycoprotein E C-end of West Nile virus and evaluation of its interaction force with alphaVbeta3 integrin as putative cellular receptor.

Bogachek MV, Zaitsev BN, Sekatskii SK, Protopopova EV, Ternovoi VA, Ivanova AV, Kachko AV, Ivanisenko VA, Dietler G, Loktev VB. Bogachek MV, et al. Biochemistry (Mosc). 2010 Apr;75(4):472-80. doi: 10.1134/s0006297910040115. Biochemistry (Mosc). 2010. PMID: 20618137

10

Immunochemical and single molecule force spectroscopy studies of specific interaction between the laminin binding protein and the West Nile virus surface glycoprotein E domain II.

Bogachek MV, Protopopova EV, Loktev VB, Zaitsev BN, Favre M, Sekatskii SK, Dietler G. Bogachek MV, et al. J Mol Recognit. 2008 Jan-Feb;21(1):55-62. doi: 10.1002/jmr.866. J Mol Recognit. 2008. PMID: 18061925

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page